These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 341133)

  • 21. Induction of antibody-dependent cellular cytotoxicity against endothelial cells by renal transplantation.
    Miltenburg AM; Meijer-Paape ME; Weening JJ; Daha MR; van Es LA; van der Woude FJ
    Transplantation; 1989 Oct; 48(4):681-8. PubMed ID: 2799923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential changes in NK and ADCC effector cell function after organ transplantation in man.
    Hegarty JH; Ramsden CW; Dowd PS; Giles GR; Guillou PJ
    Biomed Pharmacother; 1983; 37(6):266-70. PubMed ID: 6367846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of methylprednisolone in the modulation of cellular cytotoxicity and its relation to renal transplantation.
    Keown P; Stiller C; Ulan R; Lockie C; McGirr D
    Proc Eur Dial Transplant Assoc; 1978; 15():299-305. PubMed ID: 154100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homograft survival and serum-blocking factors.
    Quadracci LJ; Pierce GE; Striker GE; Tremann JA; Marchioro TL
    Transplant Proc; 1973 Mar; 5(1):649-53. PubMed ID: 4572123
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibody-induced cytotoxicity by nonsensitized lymphocytes in humans.
    Kovithavongs T; Dossetor JB
    Transplant Proc; 1973 Dec; 5(4):1739-41. PubMed ID: 4130080
    [No Abstract]   [Full Text] [Related]  

  • 26. T and B cell patterns in irreversibly rejected human renal allografts. Correlation of morphology with surface markers and cytotoxic capacity of the isolated lymphoid infiltrates.
    Busch GJ; Schamberg JF; Moretz RC; Strom TB; Tilney NL; Carpenter CB
    Lab Invest; 1976 Sep; 35(3):272-80. PubMed ID: 785094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody and lymphocyte-mediated immunologic recipient versus donor reactions before and after human renal allotransplantation--a prospective study.
    Grunnet N; Kristensen T
    Transplant Proc; 1978 Sep; 10(3):531-3. PubMed ID: 362630
    [No Abstract]   [Full Text] [Related]  

  • 28. Hyperacute and acute fulminating rejection of human renal allografts.
    Williams GM; Sterioff S; Bias W
    Transplant Proc; 1972 Dec; 4(4):665-7. PubMed ID: 4566816
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of antibody-coated liposomes as a target cell model for antibody-dependent cell-mediated cytotoxicity.
    Geiger B; Schreiber AD
    Clin Exp Immunol; 1979 Jan; 35(1):149-54. PubMed ID: 428143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between effector lymphocytes in natural and antibody-mediated cytotoxicity.
    Benczur M; Györffy G; Garam T; Varga M; Medgyesi G; Sándor M; Petranyi GG
    Immunobiology; 1979 Sep; 156(3):320-9. PubMed ID: 540970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal transplantation between histocompatible donor-recipient pairs.
    Seigler HF; Stickel DL; Gunnells JC; McCoy R; Ward FE; Anderson EE; Amos DB
    Transplant Proc; 1972 Dec; 4(4):439-46. PubMed ID: 4264867
    [No Abstract]   [Full Text] [Related]  

  • 32. Antibody-dependent cell-mediated cytotoxicity in prospective kidney transplant recipients.
    Lightbody JJ; Rosenberg JC
    J Immunol; 1974 Mar; 112(3):890-6. PubMed ID: 4590706
    [No Abstract]   [Full Text] [Related]  

  • 33. [K (killer) and NK (natural killer) cells: characteristics, functions and biological properties (author's transl)].
    Scheiner O; Rumpold H; Steiner R; Kraft D
    Wien Klin Wochenschr; 1980 Feb; 92(5):147-56. PubMed ID: 6156545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.
    Suthanthiran M; Williams PS; Solomon SD; Rubin AL; Stenzel KH
    J Clin Invest; 1984 Dec; 74(6):2263-71. PubMed ID: 6392343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antibody formation in patients and the time periods of kidney allograft functioning].
    Tsygankova ST; Belorusov OS; Boĭko OV
    Sov Med; 1984; (1):39-43. PubMed ID: 6367088
    [No Abstract]   [Full Text] [Related]  

  • 36. Antibody dependent cell mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC) in 229 sera from human renal allograft recipients.
    Descamps B; Gagnon R; van der Gaag R; Feuillet MN; Crosnier J
    J Clin Lab Immunol; 1979 Nov; 2(4):303-9. PubMed ID: 395307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ADCC against human erythrocyte target cells: role of the anti-target cell antibodies in determining lymphocyte killer activity.
    Nelson DL; Poplack DG; Holiman BJ; Henkart PA
    Clin Exp Immunol; 1979 Mar; 35(3):447-53. PubMed ID: 455783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients.
    Vacher-Coponat H; Brunet C; Lyonnet L; Bonnet E; Loundou A; Sampol J; Moal V; Dussol B; Brunet P; Berland Y; Dignat-George F; Paul P
    Nephrol Dial Transplant; 2008 Apr; 23(4):1406-14. PubMed ID: 18029366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phorbol esters enhance spontaneous cytotoxicity of human lymphocytes, abrogate Fc receptor expression, and inhibit antibody-dependent lymphocyte-mediated cytotoxicity.
    Trinchieri G; O'Brien T; Shade M; Perussia B
    J Immunol; 1984 Oct; 133(4):1869-77. PubMed ID: 6432902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human K/natural killer cells targeted with hetero-cross-linked antibodies specifically lyse tumor cells in vitro and prevent tumor growth in vivo.
    Titus JA; Perez P; Kaubisch A; Garrido MA; Segal DM
    J Immunol; 1987 Nov; 139(9):3153-8. PubMed ID: 2959724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.